A phase 2 study of bortezomib in relapsed, refractory myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/12826635

N. Engl. J. Med. 2003 Jun 26 348 26 2609-17

Download in:

View as

Triples

General Info

PMID
12826635